Find a Doctor

Louis Terriou

Hôpital Claude Huriez
Male

Bio


Louis Terriou is in Lille, France. They have been an author on 87 peer reviewed articles and participated in 1 clinical trial in the past 15 years.

Contact

Lille, FR

Latest Advances


Latest Advance
Study
  • Condition: Immune Thrombocytopenia
  • Journal: American journal of hematology
  • Treatment Used: Rituximab
  • Number of Patients: 248
  • Published —
This study assessed the long-term safety and effectiveness of rituximab in adults with immune thrombocytopenia.
Latest Advance
Study
  • Condition: Paroxysmal Nocturnal Hemoglobinuria
  • Journal: Blood advances
  • Treatment Used: Ravulizumab
  • Number of Patients: 39
  • Published —
This study evaluated the effectiveness and safety of multiple doses and regimens of ravulizumab in paroxysmal nocturnal hemoglobinuria (hemoglobin in urine; PNH) naive to complement-inhibitor treatment.
Latest Advance
Study
  • Condition: Systemic lups erythematosus
  • Journal: Rheumatology (Oxford, England)
  • Treatment Used: Thrombopoietin-receptor agonists
  • Number of Patients: 18
  • Published —
This study evaluated the safety and efficacy of thrombopoietin-receptor agonists.

All Publications
View All


Publication
Study
  • Journal: American journal of hematology
  • Published —
High dose Romiplostim as a rescue therapy for adults with severe bleeding and refractory immune thrombocytopenia.
Publication
Study
  • Journal: American journal of hematology
  • Published —
High dose romiplostim as a rescue therapy for adults with severe bleeding and refractory immune thrombocytopenia.

Contact

Lille, FR

Insurance

Contact them to find out if they accept your insurance plan.